These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32504279)

  • 1. Fibroblast growth factor 21 and grow differentiation factor 15 are sensitive biomarkers of mitochondrial diseases due to mitochondrial transfer-RNA mutations and mitochondrial DNA deletions.
    Formichi P; Cardone N; Taglia I; Cardaioli E; Salvatore S; Gerfo AL; Simoncini C; Montano V; Siciliano G; Mancuso M; Malandrini A; Federico A; Dotti MT
    Neurol Sci; 2020 Dec; 41(12):3653-3662. PubMed ID: 32504279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF21 outperforms GDF15 as a diagnostic biomarker of mitochondrial disease in children.
    Riley LG; Nafisinia M; Menezes MJ; Nambiar R; Williams A; Barnes EH; Selvanathan A; Lichkus K; Bratkovic D; Yaplito-Lee J; Bhattacharya K; Ellaway C; Kava M; Balasubramaniam S; Christodoulou J
    Mol Genet Metab; 2022 Jan; 135(1):63-71. PubMed ID: 34991945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders.
    Lehtonen JM; Forsström S; Bottani E; Viscomi C; Baris OR; Isoniemi H; Höckerstedt K; Österlund P; Hurme M; Jylhävä J; Leppä S; Markkula R; Heliö T; Mombelli G; Uusimaa J; Laaksonen R; Laaksovirta H; Auranen M; Zeviani M; Smeitink J; Wiesner RJ; Nakada K; Isohanni P; Suomalainen A
    Neurology; 2016 Nov; 87(22):2290-2299. PubMed ID: 27794108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease.
    Lehtonen JM; Auranen M; Darin N; Sofou K; Bindoff L; Hikmat O; Uusimaa J; Vieira P; Tulinius M; Lönnqvist T; de Coo IF; Suomalainen A; Isohanni P
    J Inherit Metab Dis; 2021 Mar; 44(2):469-480. PubMed ID: 32857451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of FGF21 and GDF15 with mitochondrial dysfunction in children living with perinatally-acquired HIV: A cross-sectional evaluation of pediatric AIDS clinical trials group 219/219C.
    Gojanovich GS; Jacobson DL; Broadwell C; Karalius B; Kirmse B; Geffner ME; Jao J; Van Dyke RB; McFarland EJ; Silio M; Crain M; Gerschenson M;
    PLoS One; 2021; 16(12):e0261563. PubMed ID: 34972147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Glycemic Control Decreases the Elevated Serum FGF21 Level without Affecting Normal Serum GDF15 Levels in a Patient with Mitochondrial Diabetes.
    Murakami T; Ueba Y; Shinoto Y; Koga Y; Kaneda D; Hatoko T; Kato T; Yonemitsu S; Muro S; Oki S
    Tohoku J Exp Med; 2016 Jun; 239(2):89-94. PubMed ID: 27212224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating FGF21 and GDF15 as Biomarkers for Screening, Diagnosis, and Severity Assessment of Primary Mitochondrial Disorders in Children.
    Li Y; Li S; Qiu Y; Zhou M; Chen M; Hu Y; Hong S; Jiang L; Guo Y
    Front Pediatr; 2022; 10():851534. PubMed ID: 35498801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding and validating the biomarkers for mitochondrial diseases.
    Maresca A; Del Dotto V; Romagnoli M; La Morgia C; Di Vito L; Capristo M; Valentino ML; Carelli V;
    J Mol Med (Berl); 2020 Oct; 98(10):1467-1478. PubMed ID: 32851462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseases.
    Van Hove JLK; Friederich MW; Strode DK; Van Hove RA; Miller KR; Sharma R; Shah H; Estrella J; Gabel L; Horslen S; Kohli R; Lovell MA; Miethke AG; Molleston JP; Romero R; Squires JE; Alonso EM; Guthery SL; Kamath BM; Loomes KM; Rosenthal P; Mysore KR; Cavallo LA; Valentino PL; Magee JC; Sundaram SS; Sokol RJ;
    Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38180987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fibroblast growth factor 21 concentration in children with mitochondrial disease does not depend on the disease stage, but rather on the disease genotype.
    Wesół-Kucharska D; Rokicki D; Greczan M; Kaczor M; Czekuć-Kryśkiewicz E; Piekutowska-Abramczuk D; Halat-Wolska P; Ciara E; Jaworski M; Jezela-Stanek A
    Pediatr Endocrinol Diabetes Metab; 2022; 28(2):141-151. PubMed ID: 35620925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new diagnostic indication device of a biomarker growth differentiation factor 15 for mitochondrial diseases: From laboratory to automated inspection.
    Koga Y; Povalko N; Inoue E; Ishii A; Fujii K; Fujii T; Murayama K; Mogami Y; Hata I; Ikawa M; Fukami K; Fukumoto Y; Nomura M; Ichikawa K; Yoshida K
    J Inherit Metab Dis; 2021 Mar; 44(2):358-366. PubMed ID: 32965044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast Growth Factor 21 Drives Dynamics of Local and Systemic Stress Responses in Mitochondrial Myopathy with mtDNA Deletions.
    Forsström S; Jackson CB; Carroll CJ; Kuronen M; Pirinen E; Pradhan S; Marmyleva A; Auranen M; Kleine IM; Khan NA; Roivainen A; Marjamäki P; Liljenbäck H; Wang L; Battersby BJ; Richter U; Velagapudi V; Nikkanen J; Euro L; Suomalainen A
    Cell Metab; 2019 Dec; 30(6):1040-1054.e7. PubMed ID: 31523008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of FGF21 and GDF15 in mediating the mitochondrial integrated stress response.
    Jena J; García-Peña LM; Pereira RO
    Front Endocrinol (Lausanne); 2023; 14():1264530. PubMed ID: 37818094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heightened Serum Mitochondrial Biomarkers; FGF21 and NOS in Pediatric Anemia and a Negative Correlation between GDF15 and Serum Ferritin.
    Çakmak HM; Alpay M; Mahdızadeh C; Özalp SÇ; Türay S; Özde Ş; Kocabay K
    J Clin Med; 2024 Jul; 13(15):. PubMed ID: 39124668
    [No Abstract]   [Full Text] [Related]  

  • 15. Cold exposure increases circulating fibroblast growth factor 21 in the evening in males and females.
    Hoekx CA; Martinez-Tellez B; Straat ME; Verkleij MMA; Kemmeren M; Kooijman S; Uhrbom M; de Jager SCA; Rensen PCN; Boon MR
    Endocr Connect; 2024 Jul; 13(7):. PubMed ID: 38781402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress-induced FGF21 and GDF15 in obesity and obesity resistance.
    Keipert S; Ost M
    Trends Endocrinol Metab; 2021 Nov; 32(11):904-915. PubMed ID: 34526227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated FGF 21 in myotonic dystrophy type 1 and mitochondrial diseases.
    Lovadi E; Csereklyei M; Merkli H; FüLöp K; Sebők Á; Karcagi V; Komoly S; Pál E
    Muscle Nerve; 2017 Apr; 55(4):564-569. PubMed ID: 27489983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer's disease in comparison with healthy aging.
    Conte M; Sabbatinelli J; Chiariello A; Martucci M; Santoro A; Monti D; Arcaro M; Galimberti D; Scarpini E; Bonfigli AR; Giuliani A; Olivieri F; Franceschi C; Salvioli S
    Geroscience; 2021 Apr; 43(2):985-1001. PubMed ID: 33131010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF21 in ataxia patients with spinocerebellar atrophy and mitochondrial disease.
    Su SL; Wang WF; Wu SL; Wu HM; Chang JC; Huang CS; Cheng WL; Soong BW; Lee YC; Li JY; Kuo SJ; Chen M; Huang CN; Liu CS
    Clin Chim Acta; 2012 Dec; 414():225-7. PubMed ID: 23031666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers and clinical rating scales for sodium pyruvate therapy in patients with mitochondrial disease.
    Koga Y; Povalko N; Inoue E; Nashiki K; Tanaka M
    Mitochondrion; 2019 Sep; 48():11-15. PubMed ID: 30738201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.